Pharming Group NV
AEX:PHARM

Watchlist Manager
Pharming Group NV Logo
Pharming Group NV
AEX:PHARM
Watchlist
Price: 0.7355 EUR 2.65% Market Closed
Market Cap: 498.9m EUR
Have any thoughts about
Pharming Group NV?
Write Note

Pharming Group NV
Gross Profit

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Pharming Group NV
Gross Profit Peer Comparison

Comparables:
PRQR
QURE
ARGX
MRUS
LVTX

Competitive Gross Profit Analysis
Latest Figures & CAGR of Competitors

Company Gross Profit CAGR 3Y CAGR 5Y CAGR 10Y
Pharming Group NV
AEX:PHARM
Gross Profit
$245.8m
CAGR 3-Years
-7%
CAGR 5-Years
6%
CAGR 10-Years
58%
ProQR Therapeutics NV
NASDAQ:PRQR
Gross Profit
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Uniqure NV
NASDAQ:QURE
Gross Profit
$2m
CAGR 3-Years
-83%
CAGR 5-Years
N/A
CAGR 10-Years
-7%
argenx SE
XBRU:ARGX
Gross Profit
$1.7B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Merus NV
NASDAQ:MRUS
Gross Profit
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
LAVA Therapeutics NV
NASDAQ:LVTX
Gross Profit
$3.3m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Pharming Group NV's Gross Profit?
Gross Profit
245.8m USD

Based on the financial report for Jun 30, 2024, Pharming Group NV's Gross Profit amounts to 245.8m USD.

What is Pharming Group NV's Gross Profit growth rate?
Gross Profit CAGR 10Y
58%

Over the last year, the Gross Profit growth was 31%. The average annual Gross Profit growth rates for Pharming Group NV have been -7% over the past three years , 6% over the past five years , and 58% over the past ten years .

Back to Top